Stocks · News reference

Privia Health Group shares are trading lower. The company affirmed its FY26 sales guidance with its midpoint below estimates.

Aug 6, 2026, 7:15 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 18, 2026, 1:03 PMSEC EDGAR
8-K filing — Privia Health Group, Inc. (PRVA)
Filed: 2026-08-18 AccNo: 0001759655-26-000068 Size: 172 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Read original at edgar
PRVA
BenzingaAug 6, 2026, 1:17 PMBenzinga Newsdesk
CORRECTION: Privia Health Gr Q2 Adj. EPS $0.19 Beats $0.07 Estimate, Sales $632.600M Beat $599.186M Estimate
Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.07 by 171.43 percent. This is a 11.76 percent increase over earnings of $0.17 per share from
Read original at benzinga
PRVA
BenzingaAug 6, 2026, 10:01 AMBenzinga Newsdesk
Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.422B Est
Privia Health Gr (NASDAQ:PRVA) affirms FY2026 sales outlook from $2.350 billion-$2.450 billion to $2.350 billion-$2.450 billion vs $2.422 billion estimate.
Read original at benzinga
PRVA